1. Home
  2. INZY vs SCWO Comparison

INZY vs SCWO Comparison

Compare INZY & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • SCWO
  • Stock Information
  • Founded
  • INZY 2015
  • SCWO 2021
  • Country
  • INZY United States
  • SCWO United States
  • Employees
  • INZY N/A
  • SCWO N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • INZY Health Care
  • SCWO Utilities
  • Exchange
  • INZY Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • INZY 256.3M
  • SCWO 56.4M
  • IPO Year
  • INZY 2020
  • SCWO N/A
  • Fundamental
  • Price
  • INZY N/A
  • SCWO $0.21
  • Analyst Decision
  • INZY Buy
  • SCWO
  • Analyst Count
  • INZY 9
  • SCWO 0
  • Target Price
  • INZY $15.22
  • SCWO N/A
  • AVG Volume (30 Days)
  • INZY 989.2K
  • SCWO 1.3M
  • Earning Date
  • INZY 08-05-2025
  • SCWO 08-13-2025
  • Dividend Yield
  • INZY N/A
  • SCWO N/A
  • EPS Growth
  • INZY N/A
  • SCWO N/A
  • EPS
  • INZY N/A
  • SCWO N/A
  • Revenue
  • INZY N/A
  • SCWO $673,267.00
  • Revenue This Year
  • INZY N/A
  • SCWO $5,945.19
  • Revenue Next Year
  • INZY N/A
  • SCWO $106.82
  • P/E Ratio
  • INZY N/A
  • SCWO N/A
  • Revenue Growth
  • INZY N/A
  • SCWO 161.19
  • 52 Week Low
  • INZY $0.72
  • SCWO $0.16
  • 52 Week High
  • INZY $6.24
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • INZY 82.67
  • SCWO 34.48
  • Support Level
  • INZY $3.94
  • SCWO $0.16
  • Resistance Level
  • INZY $3.97
  • SCWO $0.44
  • Average True Range (ATR)
  • INZY 0.01
  • SCWO 0.06
  • MACD
  • INZY -0.08
  • SCWO -0.03
  • Stochastic Oscillator
  • INZY 100.00
  • SCWO 17.86

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: